Manufacturing Chemist
  • Home
  • Categories
    • Ingredients
    • Analysis
    • Manufacturing
    • Finance
    • Company News
    • Regulatory
    • Drug Delivery
    • Research & Development
    • Sustainability
  • Pharma 5.0
  • Events
  • Directory
  • Search
    • Close search
  • Subscribe
  • Login
    • Password
      Password
      Forgot password? Close login form
  • Home
  • Company News

Company News

Joerg Reinhardt to leave Bayer HealthCare Joerg Reinhardt to leave Bayer HealthCare He will become director and non-executive chairman at Novartis Particle Sciences appoints director of formulation and process development Particle Sciences appoints director of formulation and process development Deepak Tiwari joins the company with 18 years of pharma development experience Microbiology specialist joins Cherwell Laboratories Microbiology specialist joins Cherwell Laboratories Abdulmajeed Raji takes up the newly created position Peder Holk Nielsen to become president and CEO of Novozymes Peder Holk Nielsen to become president and CEO of Novozymes With effect from 1 April Rieke Dispensing appoints European sales director Rieke Dispensing appoints European sales director Nicolas Lemaigre-Voreaux will drive growth throughout Europe, the Middle East and Africa Bayer Technology Services appoints head of Operation Support and Safety Bayer Technology Services appoints head of Operation Support and Safety Thomas Steckenreiter takes role as Norbert Kuschnerus retires John Reed to join Roche Pharma Research and Early Development John Reed to join Roche Pharma Research and Early Development Takes up role as head of pRED in April AstraZeneca makes changes to senior executive team AstraZeneca makes changes to senior executive team Will see departure of Martin Mackay and Tony Zook Lundbeck appoints VP of global pricing and market access Lundbeck appoints VP of global pricing and market access Plans launch of three products this year Andrea Rappagliosi becomes president of Vaccines Europe Andrea Rappagliosi becomes president of Vaccines Europe He is VP of Market Access, Health Policy & Medical Affairs at Sanofi Pasteur MSD Tim Mayleben rejoins Esperion as president and CEO Tim Mayleben rejoins Esperion as president and CEO Founder Roger Newton will become chairman and CSO Bayer names Early Excellence in Science prize winners Bayer names Early Excellence in Science prize winners Three young scientists are awarded €10,000 each SCM strengthens quality team SCM strengthens quality team Appoints Mark Edwards as Quality Assurance director AMRI promotes Richard Saffee to VP and general manager of large-scale manufacturing AMRI promotes Richard Saffee to VP and general manager of large-scale manufacturing Will drive synergies between locations in India, the UK and the US Sanofi appoints chairman of SDSAC Sanofi appoints chairman of SDSAC Dr Gary Nabel succeeds Dr Richard Klausner Cell Therapy Catapult makes three senior appointments Cell Therapy Catapult makes three senior appointments Focused on the development of the UK cell therapy industry Dow CEO wins 2013 SCI Chemical Industry Medal Dow CEO wins 2013 SCI Chemical Industry Medal Andrew Liveris is 6th Dow leader to receive the Medal since 1933 Sanofi president of Global Operations to retire mid-2013 Sanofi president of Global Operations to retire mid-2013 Hanspeter Spek joined the company in 1985 Amgen makes changes to board Amgen makes changes to board They will come into effect on 1 January 2013 Victrex team goes the distance for charity Victrex team goes the distance for charity Peak District hike raises funds for The Christie in Manchester Dr Rabinder Buttar wins Scottish Asian Business Award Dr Rabinder Buttar wins Scottish Asian Business Award ClinTec sees 15th year of continued growth Michael Koenig appointed to Bayer board of management Michael Koenig appointed to Bayer board of management Dr Richard Pott to retire, effective 1 June 2013 Sygnature Discovery appoints VP of Business Development – North America Sygnature Discovery appoints VP of Business Development – North America Plans to expand customer base in the US and Canada over next two years Charlie Morris joins Almac’s clinical technologies team Charlie Morris joins Almac’s clinical technologies team Will oversee development of IXRS technology
  • Previous
  • 1
  • …
  • 96
  • 97
  • 98
  • 99 (current)
  • 100
  • 101
  • 102
  • …
  • 142
  • Next

Trending Articles

  1. Envair Technology appoints new sales director to accelerate global growth Orders up 20% year on year as demand for clean air solutions increases across higher education, pharma and healthcare sectors
  2. Sygnature Discovery strengthens in vivo pharmacology leadership with appointment of Susanne Back The appointment of Susanne Back as Head of In Vivo Pharmacology will further strengthen its bioscience leadership and reinforcing its commitment to delivering high-quality, integrated drug discovery solutions for customers worldwide
  3. Kindeva appoints Mike Cowhig as Chief Legal Officer The appointment will drive legal strategy, enterprise risk management and corporate governance across the organisation
  4. Saharsh Davuluri to take over as CEO & MD of Neuland and lead the next phase of CDMO expansion Announcement follows several years of stellar growth and points to a sharper focus on expanding commercial NCE opportunities
  5. FUJIFILM Biotechnologies Appoints Christiane Bardroff as Chief Business Officer FUJIFILM Biotechnologies, a world-leading contract development and manufacturing organisation (CDMO) for biologics, vaccines, and advanced therapies, announced the appointment of Christiane Bardroff as Chief Business Officer (CBO), effective June 1, 2026

Upcoming event

Making Pharmaceuticals

21–22 April 2026 | Exhibition | Coventry, UK
See all

Become a Subscriber

Subscribe now Already a subscriber? Sign in here. Find out more

Get our newsletter

Follow us

  • LinkedIn
  • About Manufacturing Chemist
  • About HPCi Media
  • Newsletter sign up
  • Contact Us
  • Advertise
  • Terms and Conditions
  • Privacy
© HPCi Media Limited | Registered in England No. 06716035 | VAT GB 939828072 | a Claverley Group company Registered office address:
One Anchorage Avenue,
Shrewsbury Business Park,
Shrewsbury,
SY2 6FG, UK.